Saturday, 11 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Health and Wellness > Coverage Of Weight Loss Drugs By Medicaid Plans Continues To Lag
Health and Wellness

Coverage Of Weight Loss Drugs By Medicaid Plans Continues To Lag

Last updated: August 7, 2025 10:00 am
Share
Coverage Of Weight Loss Drugs By Medicaid Plans Continues To Lag
SHARE

States across the country are facing budget challenges that are impacting healthcare coverage, particularly for weight loss treatments. California recently passed a budget for 2025-2026 that eliminates Medicaid coverage for GLP-1 agonists for weight loss, and other states are considering similar cuts. The enactment of The Big Beautiful Bill is adding further pressure on state budget finances, making it unlikely that Medicaid coverage for weight loss treatments will expand in the near future.

The obesity epidemic in the United States is a major concern, with nearly 40% of adult Americans considered obese. Rates of obesity have been steadily rising since 1980, leading to an increased risk of developing conditions such as diabetes, heart disease, osteoarthritis, and various cancers. Medications known as glucagon-like peptide-1 agonists, or GLP-1s, have become popular as weight loss agents. When taken as directed, along with a proper diet and exercise regimen, GLP-1s have been effective in helping individuals lower their weight.

However, coverage for these medications remains a challenge, with commercial insurance coverage improving but still not universal. In Medicare, coverage of GLP-1s for weight loss alone is prohibited, although obese patients can access the semaglutide-based product, Wegovy, for heart disease. Medicaid generally does not reimburse GLP-1s for obesity, with only 14 states covering obesity medications in their state Medicaid plans.

With significant Medicaid cuts resulting from the passage of The Big Beautiful Bill, more states are likely to follow suit in cutting coverage for obesity medications. The new legislation limits how states can fund their share of Medicaid costs, leading to potential cuts in a wide range of Medicaid benefits. States that do opt to cover weight loss treatments often impose restrictive eligibility requirements and utilization management tools to control costs.

See also  Google reportedly plans to cut ties with Scale AI

While there is a possibility that some state Medicaid agencies may elect to cover weight loss drugs for “weight management” through a voluntary demonstration project, details and incentives for participation remain unclear. The high cost of these therapeutics is a primary concern for payers, with potential budget impacts for commercial insurers and public sector payers like Medicaid.

In addition to cost considerations, lack of persistence on GLP-1s is another factor contributing to hesitance in reimbursing weight loss drugs. Patients often discontinue treatment at a high rate, leading to little or no benefit and added costs for payers. As net prices of GLP-1s decrease and more data shows the benefits of consistent use in conjunction with diet and exercise, there may be a reconsideration of coverage decisions in the future. Until then, coverage for weight loss treatments will continue to be a significant challenge for payers.

TAGGED:continuesCoverageDrugslagLossMedicaidPlansWeight
Share This Article
Twitter Email Copy Link Print
Previous Article ACC sees rise in injuries caused by working out ACC sees rise in injuries caused by working out
Next Article Vodafone & Three Merger Complete: What It Means For You Vodafone & Three Merger Complete: What It Means For You
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

What did Ryan Reynolds say about the Blake Lively-Justin Baldoni saga? Perez Hilton says legal feud has “not affected” the actor professionally

Podcaster Perez Hilton Weighs in on Ryan Reynolds' Response to Blake Lively vs Justin Baldoni…

June 27, 2025

New England Closes the Door on Coal. Cheaper Renewables Can Take Its Place.

 Coal has seen a steady decline in New England, with coal generation falling by over 90% in the decade…

October 8, 2025

iProov: 70% of organizations will be greatly impacted by gen AI deepfakes

Deepfakes have become a major concern for organizations around the world, with nearly half of…

August 29, 2024

3thix partners with Avalanche on web3 gaming ad data

3thix Partners with Avalanche to Launch Decentralized Ad-Tech Layer Web3 finance company 3thix has announced…

October 3, 2024

Volvo Group and Daimler Truck partner to launch Coretura

Volvo Group and Daimler Truck have officially launched Coretura, a joint venture dedicated to developing…

June 20, 2025

You Might Also Like

President Trump is in ‘exceptional health,’ his doctor says, after visit to Walter Reed
Health and Wellness

President Trump is in ‘exceptional health,’ his doctor says, after visit to Walter Reed

October 10, 2025
After 10 Years, the ‘Alone’ Franchise Continues to Strike a Chord With Viewers
Entertainment

After 10 Years, the ‘Alone’ Franchise Continues to Strike a Chord With Viewers

October 10, 2025
STAT+: HHS employees to be fired as White House enacts mass terminations it blames on shutdown
Health and Wellness

STAT+: HHS employees to be fired as White House enacts mass terminations it blames on shutdown

October 10, 2025
Meghan Markle’s High-Fashion Streak Continues in Armani
Lifestyle

Meghan Markle’s High-Fashion Streak Continues in Armani

October 10, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?